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1. Practical Instructions for
section 3.1: glossary of uncertain
terms
The literature on syncope and associated conditions can be confusing
because of a lack of consistency. The meaning of some terms has
become obscured, and new terms were introduced to compete with
older, often equally adequate ones. Regional differences exist in the
interpretation of various words. This glossary is provided to clarify the
nomenclature and improve consistency with the European Society of
Cardiology (ESC) definitions of syncope and related concepts.
1.1 Blackout
The word ‘blackout’ seems to be used mostly in the UK, where it cor-
responds with transient loss of consciousness (TLOC)—as in the
ESC sense—as proven by the title of the UK National Institute for
Health and Care Excellence guideline: “Transient loss of consciousness
(“blackouts”) in over 16s (CG109)”. In the introduction, the authors
state that the medical term for ‘blackout’ is TLOC.
‘Blackout’ suggests that it has an origin in the loss of vision that
people may experience just before unconsciousness in syncope. The
fact that retinal hypoperfusion can be noticed suggests that retinal
function is lost ahead of cerebral function, due to intracranial pres-
sure or other retinal perfusion characteristics. Such loss of vision
does not occur in other TLOC causes and is not universal in syncope,
so blackout in its literal sense does not fit syncope or TLOC well.
• Blackout is too regional and imprecise to be used in a scientific
setting; however, it may be useful in communication with
patients.
1.2 Breath-holding spells
Breath-holding spells concern attacks of TLOC in infants. Two types
are usually recognized: pallid and cyanotic. The pallid type concerns
bradycardia or asystole triggered by fear and pain,1 so these attacks
represent cardioinhibitory vasovagal syncope (VVS). There is no
appreciable contribution of respiration to the pathophysiology of
these attacks.1 Hence, for pallid breath-holding spells, the name
‘breath holding’ is a misnomer. In the cyanotic type, respiration plays
a crucial role: attacks start with the child being hurt or startled, after
which respiration ceases in expiration.2 The circulation may become
impaired secondarily, in turn causing unconsciousness. This unique
pathophysiological pattern is not known in older children or adults.
Both pallid and cyanotic types may occur in the same child, implying a
susceptibility towards abnormal autonomic reflex activity, either
inhibiting the circulation or the respiration.
The term ‘breath holding’ may be taken to mean that children do
so voluntarily, which is not the case in these two forms. Some
ESC Guidelines e45
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children may hold their breath voluntarily, but it is almost certainly
impossible to lose consciousness this way.
• Pallid breath-holding spells concern cardioinhibitory VVS in
small children; respiration is not involved in the pathophysiology.
Instead of breath-holding spells, terms such as cardioinhibitory
VVS are advocated to reduce confusion.
• Cyanotic breath-holding spells represent a unique form of
TLOC in small children in which a reflex action produces invol-
untary expiratory apnoea followed by secondary circulatory
events.
1.3 Convulsive syncope
Convulsion means violent contractions of muscles; in neurological
terminology, an individual abrupt involuntary movement is called
myoclonus. Myoclonus in syncope occurs when the electroencepha-
logram (EEG) is slow but not flat.3 Myoclonus occurs often enough in
syncope to state that the mere presence of myoclonus is not suffi-
cient evidence for an epileptic seizure. That distinction instead
depends on the synchrony, rhythmicity, and probably the number of
the movements: in syncope, there are few such movements and
many (20–100) in generalized seizures.
• The term convulsive syncope does not imply epileptic seizures.
The presence of myoclonus in syncope does not imply severe
hypoperfusion or any specific cause for syncope, so adding the
word convulsive to syncope has no clear advantage.
1.4 Drop attacks
The term ‘drop attacks’ may be used as a description of sudden falls,
occurring without clear warning signs or symptoms and without an
obvious external cause such as stumbling over an object. Patients
may describe a fall as a ‘drop attack’; usually they have no awareness
of loss of consciousness (LOC). Such episodes should be classified as
unexplained or non-accidental falls rather than drop attacks.
In the purely descriptive sense, drop attacks do not imply any spe-
cific cause. However, the term is also used for no less than three spe-
cific disorders: in epilepsy it can be used to describe atonic seizures;
in Menie`re’s disease it may be used for sudden falls without vertigo;
and one variant describes a specific syndrome of unknown origin in
which middle-aged and elderly women suddenly fall while walking,
usually to their knees, without LOC.4
• The term ‘drop attack’ may be used as a non-specific descriptor
of falls but does not constitute a diagnosis.
• In the context of falls, the term ‘unexplained’ or ‘non-accidental
falls’ is preferred over ‘drop attacks’.
• The term ‘drop attacks’ can be used to indicate a specific form
of falling occurring in middle-aged and elderly women4 for
whom no other term seems appropriate.
1.5 Dysautonomia/dysautonomic
When used as part of ‘familial dysautonomia’ (Riley–Day syndrome),
the term has a specific and clear meaning. However, beyond that con-
text, dysautonomia is used for any abnormal function of the auto-
nomic nervous system, bundling fundamentally different disorders
such as neurogenic orthostatic hypotension (OH), reflex syncope,
and postural orthostatic tachycardia syndrome (POTS). In some
contexts, the word is reserved for a subset of the disorders encom-
passing autonomic medicine, i.e. disorders causing neurogenic OH.
• ‘Dysautonomia’ has a clear place in the term ‘familial dysautono-
mia’ (Riley–Day syndrome).
• For scientific use, specific terms indicating disorders or groups of
disorders that share a common pathophysiology are preferred
over the non-specific term ‘dysautonomia’.
• Disorders characterized by an abnormally decreased function of
the autonomic nervous system, mostly causing neurogenic OH,
are preferably labelled ‘autonomic failure’.
1.6 Faint
The noun ‘faint’ may be a colloquial synonym for ‘syncope’, but in
that context, is probably used more often for VVS than for ‘syncope
regardless of cause’. The verb ‘to faint’ has the same connotations.
• The verb ‘to faint’ and noun ‘faint’ are too imprecise to be used
in a scientific context, but may be useful to facilitate communica-
tion with patients.
1.7 Hyperventilation syncope
The role of hyperventilation in syncope is complex: hyperventilation
reduces cerebral blood flow through vasoconstriction, but also
(through negative intrathoracic pressure) increases venous return
with positive effects. The net effect on the systemic and cerebral cir-
culation in various causes of syncope is imperfectly known. Note that
the term ‘hyperventilation syndrome’ is included in the Diagnostic
Statistical Manual Fifth Edition, but the symptoms are much closer to
panic attacks than to syncope. Hence, emotional and circulatory
effects linked to hyperventilation may play a role in evoking syncope,
but there is too little evidence to regard hyperventilation as the major
cause.
• There is no reason to recognize ‘hyperventilation syncope’ as a
specific entity.
1.8 Neurally mediated syncope
Neurally mediated syncope is a synonym for ‘reflex syncope’. Like
‘reflex syncope’, it emphasizes the role of the autonomic nervous sys-
tem in the disruption of normal circulatory control. Unlike ‘reflex
syncope’, it does not emphasize the role of a trigger in eliciting syn-
cope. Note that syncope due to OH might literally also fit the phrase
‘neurally mediated syncope’; in practice, it is reserved for reflex
syncope.
• Neurally mediated syncope is accepted as a synonym of reflex
syncope.
1.9 Neurocardiogenic syncope
The term neurocardiogenic syncope occurs in the literature either as
an alternative for reflex syncope or for VVS, making it ambiguous.
The term ‘vasovagal’ is older, simpler, more common, and more apt,
as it stresses both the vasodepressive (‘vaso. . .’) and cardioinhibitory
(‘. . .vagal’) effector pathways. Reflex syncope is preferred over ‘neu-
rocardiogenic’ for similar reasons. Moreover, the word ‘neurocardio-
genic’ does not clearly indicate what the ‘neuro’ and ‘cardio’ parts
represent; the term apparently ignores the vasodepressive
mechanism.
e46 ESC Guidelines
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.• There is no need for more synonyms for reflex syncope or
VVS, so ‘neurocardiogenic’ should be replaced by one of these
terms.
1.10 Neurological syncope
The phrase ‘neurological syncope’ is rarely defined. When encoun-
tered, its use suggests that ‘syncope’ was not used in the ESC sense
but in a much wider sense, probably corresponding to TLOC.
Although the autonomic nervous system is involved in reflex syn-
cope, syncope due to OH, and even in cardiovascular syncope, there
is no need to label any expression of this involvement as
‘neurological’.
• There is no need for the term ‘neurological syncope’; specific
terms should be used instead.
1.11 Postural orthostatic tachycardia
syndrome
POTS is also called ‘postural tachycardia syndrome’. The word ‘pos-
tural’ is not limited to any specific posture, whereas ‘orthostatic’ spe-
cifically means standing upright (originating from the Greek words for
upright and standing). There is little chance of misunderstanding, as
the abbreviations of both forms of the name are ‘POTS’ (sometimes
‘PoTS’), and all descriptions and definitions stress standing as a factor
provoking complaints and tachycardia.
• As ‘orthostatic’ in POTS stresses the upright position, this var-
iant is preferred over ‘postural tachycardia syndrome’.
1.12 Psychogenic syncope
Patients may exhibit signs of unconsciousness even when somatic
brain function is normal. Spells of apparent unconsciousness without
gross body and limb movements are most often called ‘psychogenic
pseudosyncope’ (PPS). The term stresses what the attacks look like
(i.e. syncope) but are not (i.e. pseudo), while stating their origin (i.e.
psychogenic). During such attacks, there is no cerebral hypoperfu-
sion, so ‘syncope’ is incorrect.
• The term psychogenic syncope is pathophysiologically incorrect.
PPS is the preferred term for the form of psychogenic TLOC
that outwardly resembles syncope.
1.13 Reflex anoxic seizure
The term ‘reflex anoxic seizure’ designates syncopal attacks in infants,
particularly those with myoclonus. The use of ‘seizure’ in ‘reflex
anoxic seizures’ was not intended to imply epilepsy, but only to
describe an attack without any specific pathophysiological connota-
tions. However, for many, the word seizure is strongly associated
with epilepsy. As such attacks in children are often mistaken for epi-
lepsy through superficially similar signs, their terminology should pre-
vent confusion as much as possible. Also see ‘breath-holding spells’.
• The phrase ‘reflex anoxic seizures’ denotes reflex syncope in
small children. To avoid confusion with epileptic seizures, spe-
cific terms such as ‘VVS in infants’ are preferred.
1.14 Seizures
For some, the word seizure refers to attacks that may include epi-
lepsy as well as syncope. The term ‘psychogenic non-epileptic seiz-
ures’ (PNES) also suggests that seizures are not limited to epileptic
seizures. Still, for many people, seizures suggest epileptic attacks. If
the meaning is ambiguous, there is a risk of mistaking syncope for
epilepsy.
• To avoid confusion between syncope and epileptic seizures, it is
best not to use ‘seizure’ in a wide sense that includes syncope.
• Use of the term ‘epileptic seizures’ is advocated whenever con-
fusion is possible.
1.15 Vasodepressor/vasodepressive
syncope
In the older literature, the term ‘vasodepressor/vasodepressive syn-
cope’ was used as an alternative for VVS. The distinction between
the two effector pathways of reflex syncope means that its current
meaning is restricted to one such pathway, the other being cardioin-
hibitory. Note that ‘vasodepressor’ in the context of reflex syncope
refers to an abnormal decrease of sympathetic vasoconstriction, the
effect of which is vasodilatation.
• ‘Vasodepressor’ is best used to denote a pathophysiological
mechanism of reflex syncope, and ‘vasodepressor syncope’ only
for reflex syncope without bradycardia.
2. Practical Instructions for
section 3.2.: classification,
pathophysiology, epidemiology,
prognosis, quality of life, and costs
2.1 Pathophysiology
2.1.1 Reflex syncope
In reflex syncope, the afferent pathways (shown in red in Web
Figure 1) transfer information from the circulatory and visceral recep-
tors to the brain. Haemodynamic instability (evidenced by central
hypovolaemia, hypotension, and/or tachycardia), gastrointestinal
symptoms, pain, and other triggers can activate the reflex. Higher brain
functions such as emotional triggers can also facilitate activation of the
reflex or trigger it directly. The main efferent components of the reflex
(shown in blue in Web Figure 1) are bradycardia or asystole, as well as
dilation of capacitance vessels in the splanchnic region and lower limbs,
with consequent hypotension. The combination of vasodepressive
effects and bradycardia to varying degrees results in manifestations
such as vasodepressor, cardioinhibitory, or mixed reflex syncope.
Most episodes of syncope occur in the upright posture. Basic to
the understanding of syncope is the concept of central blood volume
(i.e. the reservoir of blood available in the four cardiac chambers and
in the pulmonary and great thoracic vessels). A low central blood vol-
ume due to venous pooling below the diaphragm is a main causative
factor in syncope, as the heart can never pump out more blood than
flows in.5 The key circulatory adjustments to the upright posture are
the constriction of arterioles and venous capacitance vessels in the
splanchnic area, and an increase in skeletal and abdominal muscle
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tone causing an increase in venous return. Control of vasomotor
function by the arterial baroreflex is the key in rapid hemodynamic
adjustments to the upright posture.
The pathophysiology of orthostatic VVS deserves mention. In it, syn-
cope is preceded by a period of 4–6 min in which the blood pressure
(BP) is unstable and decreases slightly.6 Baroreceptor malfunctioning
may disorganize the discharge activity of vascular sympathetic fibres,
thus leading to ineffective vasoconstrictor activity before syncope.7
This is caused by a progressive decrease in cardiac output, presumably
due to venous pooling of blood below the diaphragm. The decrease in
cardiac output is more important than the decrease in total peripheral
resistance, which does not decrease in all subjects and may even
increase.6,8–11 Peripheral resistance may only decrease before syncope
in vasodepressive but not ‘pure’ cardioinhibitory syncope.12 These pro-
gressive circulatory changes finally trigger the reflex in which cardioinhi-
bition and vasodepression (i.e. vasodilatation) play their role.13–15
Finally, efferent mechanisms other than simple sympathetic inhibi-
tion may account for reflex syncope, including the recently suggested
Web Figure 1 The mechanism of reflex syncope: anatomical view. Afferent pathways (shown in red) transfer information from the circulatory
and visceral receptors to the brain. Arterial baroreceptors are in the aortic arch and the carotid sinus; these are stretch receptors that are activated
when distended by an increase in arterial pressure. Afferent nerve fibres from the carotid sinus and the aortic arch join the glossopharyngeal nerves
(IX) and vagus nerves (X), respectively, toward the vasomotor centres in the brainstem. Higher brain functions (emotional triggers) can also activate
the reflex. The efferent pathways (shown in blue) consist of the vagus nerve to the heart and sympathetic fibres to the heart and blood vessels. The
effector paths are bradycardia/asystole, and the dilation of vasoconstrictor vessels and capacitance vessels in the splanchnic bed.
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increased activity of the norepinephrine transporter protein. This
would clear noradrenaline more rapidly, reducing vasoconstriction.16
2.1.2 Orthostatic hypotension and other
syndromes of orthostatic intolerance
In syncope due to OH, functional and structural impairments of the
autonomic nervous system lead to an inadequate increase in periph-
eral resistance and heart rate (HR) upon standing. In primary and sec-
ondary autonomic failure, cardiovascular sympathetic fibres are
unable to increase total peripheral vascular resistance in the upright
posture. Gravitational stress, in combination with vasoconstrictor,
chronotropic, and inotropic failure, results in venous pooling of blood
below the diaphragm and a decrease in venous return and carbon
dioxide, resulting in a low BP.
Web Figure 2 depicts the afferent pathway (shown in red), which
transfers information from the arterial baroreceptors in the carotid
arteries and aortic arch. The information reaches the vasomotor
centre in the medulla oblongata. The efferent pathway (shown in
blue) regulates two basic cardiovascular responses: HR and vascular
tone. An increase in vascular tone is key, the HR increase is not an
important contributor. Degeneration of autonomic nuclei within the
central nervous system and/or peripheral autonomic denervation
may lead to the hallmark of autonomic failure, OH, and finally
syncope.17
The circulatory autonomic causes of orthostatic intolerance include
classical OH, initial OH, delayed OH, POTS, and VVS, which in this
context can be called orthostatic VVS.18,19 Syndromes of orthostatic
intolerance that may cause syncope are presented in Web Table 1.
Web Figure 2 The mechanism of autonomic failure (orthostatic hypotension). The afferent pathway (shown in blue) transfers information from
the arterial baroreceptors in the carotid arteries and aortic arch to the vasomotor centre in the medulla oblongata. The efferent pathway (shown in
red) regulates two basic cardiovascular responses: heart rate and vascular tone. ANS = autonomic nervous system; HR = heart rate.
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..• Classical OH is defined as a sustained decrease in systolic BP
>_20 mmHg, diastolic BP >_10 mmHg, or a sustained decrease in
systolic BP to an absolute value <90 mmHg within 3 min of
active standing or head-up tilt of at least 60 degrees.18 In cases of
supine hypertension, a systolic BP drop >_30 mmHg should be
considered. Orthostatic HR increase is blunted in neurogenic
OH [usually <10 beats per minute (b.p.m.)], because autonomic
HR control is impaired. In contrast, the orthostatic HR increase
is preserved, or even enhanced, in OH due to hypovolaemia.
Classical OH may be symptomatic or asymptomatic. Symptoms
depend more on the absolute BP level than the magnitude of
the fall.20 Their occurrence likely also depends on a key role of
cerebral autoregulation.21 The severity of symptoms varies
widely among patients, which has therapeutic implications.
Classical OH is associated with increased mortality and cardio-
vascular disease prevalence.22
• Initial OH is characterized by a BP decrease on standing of >40
mmHg for systolic BP and/or >20 mmHg for diastolic BP within
15 s of standing.18 BP then spontaneously and rapidly returns to
normal, so the period of hypotension and symptoms is short
(<40 s) but may still cause syncope. Recent findings indicate that
the rate at which BP climbs after an initial fall on standing up has
important prognostic consequences: impaired recovery repre-
sents a negative prognostic factor in the elderly.23,24
• Delayed OH is defined as OH occurring beyond 3 min of head-up
tilt or active standing.18 It is characterized by a slow progressive
decrease in BP. The absence of bradycardia helps to differentiate
delayed OH from reflex syncope. However, the progressive
....................................................................................................................................................................................................................
Web Table 1 Syndromes of orthostatic intolerance that may cause syncope
Syndrome Ancillary test
for diagnosis
Time from
upright position
to abnormal BP
response
Pathophysiology Most frequent
symptoms
Most frequent associ-
ated conditions
Initial OH Beat-to-beat BP
on active standing
test (lying to
standing)
0–15 seconds Transient mismatch
between cardiac output
and total peripheral
resistance
Light-headedness, dizzi-
ness, visual disturbances a
few seconds after standing
up (syncope rare)
Young, asthenic subjects;
old age, drug-induced
(alpha-blockers)
Classical OH Active standing
test; TTT
<3 minutes Impaired increase in total
peripheral resistance and
HR in autonomic failure
resulting in pooling of
blood; alternately, severe
volume depletion
Dizziness, light-headed-
ness, fatigue, weakness,
visual and hearing
disturbances,
Frailty, drug-induced (any
vasoactive drugs and diu-
retics), autonomic failure,
hypovolaemia
Delayed
OHsometimes
followed by
reflex syncope
TTT; active stand-
ing test
>3 minutes Pathophysiology uncer-
tain. Progressive fall in
venous return and low
cardiac output are likely
Prolonged prodromes
(dizziness, light-headed-
ness, fatigue, weakness,
visual and hearing distur-
bances, low back pain,
neck or precordial pain)
that may be followed by
reflex syncope
Frailty, incipient auto-
nomic failure, drug-
induced (any vasoactive
drugs and diuretics),
comorbidity
Orthostatic vaso-
vagal syncope
TTT Usually prolonged
standing
Vasovagal reflex due to
progressive pooling of
blood with final vasode-
pressive and/or cardioin-
hibitory pathways, often
preceded by autonomic
activation
Autonomic activation
(nausea, pallor, sweating)
precedes syncope
More common in
women. Orthostatic VVS
may be associated with
chronic orthostatic
intolerance
POTS Active standing
test; or TTT
<10 minutes
Abnormal HR
response
Inappropriate HR increase
without concomitant BP fall.
Likely mechanisms: severe
deconditioning, immune-
mediated processes, exces-
sive venous pooling and
hyperadrenergic state.
Orthostatic intolerance
(light- headedness, palpi-
tations, tremor, weakness,
blurred vision, and
fatigue). Syncope is rare
and usually elicited by vas-
ovagal reflex activation.
Young women overre-
presented, recent infec-
tion or trauma, joint
hypermobility syndrome
BP = blood pressure; HR = heart rate; OH = orthostatic hypotension; POTS = postural orthostatic tachycardia syndrome; VVS = vasovagal syncope; TTT = tilt-table test.
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decrease in central blood volume caused by delayed OH may
induce reflex syncope. Delayed OH is not uncommon in elderly
persons, in whom it is attributed to stiffer hearts, sensitive to a
decrease in preload and impairment of compensatory vasocon-
strictor reflexes.17,25 It may also represent a mild form of classical
OH, especially if associated with Parkinsonism or diabetes.26,27
• POTS: some patients, mostly young women, present with
severe orthostatic intolerance (light- headedness, palpitations,
tremor, generalized weakness, blurred vision, and fatigue) and a
marked orthostatic HR increase (>30 b.p.m., or >120 b.p.m.
within 10 min of standing or head-up tilt in the absence of OH.
In patients of 12–19 years of age, HR increase should be >40
b.p.m.18 VVS may sometimes follow. POTS is frequently associ-
ated with deconditioning, recent infections, chronic fatigue
syndrome, joint hypermobility syndrome, and a spectrum of
non-specific symptoms such as headache and chest pain. The
pathophysiology is debated and likely heterogeneous: decondi-
tioning, immune-mediated processes, excessive venous pooling,
and a hyperadrenergic state have been proposed.28,29
The BP fall of orthostatic VVS differs from that in classical OH. In
VVS the BP drop starts several minutes after standing up and the rate
of BP drop accelerates until people faint, lie down, or do both.
Hence, low BP in orthostatic VVS is short-lived. In classical OH, the
BP drop starts immediately on standing and the rate of drop
decreases, so low BP may be sustained for many minutes.30
History taking in patients with orthostatic intolerance may reveal
the following:28,31
(1) Dizziness, light-headedness, weakness, fatigue, and or lethargy.
(2) Palpitations (may refer to abnormal beats in cardiac syncope, but
also to sinus tachycardia in reflex syncope, OH, and POTS).
(3) Pallor, sweating, and/or nausea: autonomic activation (reflex syncope).
(4) Pain in the neck and shoulder region (coat hanger pain), low back
pain, or precordial pain (classical OH, mostly autonomic failure).
(5) Hearing disturbances: impaired hearing, crackles, tinnitus, and/or
sounds as if from a distance (all causes).
(6) Visual disturbances: blurring, enhanced brightness, loss of colour,
tunnel vision, and finally loss of vision (all causes).
(7) Syncope.
These symptoms typically develop upon standing, are relieved by
sitting or lying, and may be worse in the morning, with heat exposure,
and after meals or exertion.
2.1.3 Cardiac syncope
Primary bradyarrhythmias such as sick sinus syndrome, atrioventricu-
lar (AV) block, and tachyarrhythmias (supraventricular or ventricular)
are the most common causes of cardiac syncope. Patients with struc-
tural heart disease (myocardial infarction or hypertrophic cardiomy-
opathy) may also present with syncope, usually due to arrhythmia.
Pulmonary embolism is a frequently underdiagnosed cause in patients
hospitalized for syncope.32
2.1.3.1. Arrhythmias
Arrhythmias are the most common cardiac cause of syncope. They
all cause syncope through a critical decrease in cardiac output, but
there are multiple contributory factors: the type of arrhythmia
(supraventricular or ventricular), ventricular rate (too low or too
high), left ventricular (LV) function, posture, and adequacy of vascular
compensation. The latter includes baroreceptor-mediated vasocon-
strictor reflexes induced by a sudden hypotension.33,34
In sick sinus syndrome, the sinoatrial node is dysfunctional, either
because of abnormal automaticity or sinoatrial conduction abnormal-
ities. In this situation, syncope is due to long pauses caused by sinus
arrest or sinoatrial block and a failure of the escape mechanism, and
may also be reflex in origin.35
As a rule, severe forms of acquired AV block (Mobitz II block, ‘high
grade’, and complete AV block) are most closely related to syncope.
In these cases, the cardiac rhythm may become dependent on subsid-
iary or escape (often unreliable) pacemaker sites such as nodal or idi-
oventricular rhythm.
Syncope or presyncope may occur at the onset of paroxysmal
tachycardia, before vascular compensation develops.33,34 Conscious-
ness is, in general, restored before tachycardia terminates, but uncon-
sciousness may persist, especially when ventricular rate is high or
ventricular activity is ineffective.
Several drugs can cause bradyarrhythmias and tachyarrhythmias.
Drugs prolonging the QT interval may promote torsade de pointes
in association with bradycardia and pauses [acquired long QT syn-
drome (LQTS)], particularly in a setting of low potassium and magne-
sium level. In contrast, in congenital LQTS, arrhythmias often follow a
sudden adrenergic rise due to exercise, arousal, sudden auditory
stimuli, or an abrupt fright. QT-prolonging drugs belong to different
categories, e.g. antiarrhythmics, vasodilators, psychotropics, antimi-
crobials, and non-sedating antihistamines. More is known about
inherited LQTS than about drug-induced LQTS. This Task Force rec-
ommends checking dedicated and up-to-date websites (www.credi
blemeds.org and www.brugadadrugs.org).
2.1.3.2. Structural heart and great vessel diseases
Structural cardiovascular diseases can cause syncope when circulatory
demands outweigh the impaired ability of the heart to increase cardiac
output. Syncope is of great concern when associated with fixed or
dynamic obstruction to LV outflow. Nonetheless, syncope is often not
solely the result of restricted cardiac output: it may be due in part to a
vasovagal reflex, OH, or arrhythmia. Similarly, pulmonary embolism
may not infrequently be accompanied by reflex syncope. Involvement
of a reflex mechanism in pulmonary embolism has been hypothesized
to explain syncope in these patients, even if the extent of pulmonary
arterial obstruction is very limited and unlikely to cause severe haemo-
dynamic compromise directly.36 Furthermore, arrhythmias, particularly
ventricular, are frequently important causes of syncope in structural
heart disease such as myocardial infarction or hypertrophic cardiomy-
opathy. Thus, the mechanism of syncope may be multifactorial.
However, even when syncope in cardiac disease may be primarily due
to a reflex, these events should be categorized as cardiac syncope, to
stress the need to correct the underlying structural disease, if possible.
2.2 Epidemiology
2.2.1 Prevalence of syncope in the general population
TLOC events of suspected syncopal nature are extremely frequent
in the general population.37 An epidemiological study performed in
the state of Utah38 showed that the yearly prevalence of syncope
resulting in medical evaluation was 9.5 per 1000 inhabitants, with 1 in
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..10 patients hospitalized. The majority of individuals with syncope
probably do not seek medical evaluation. Only a small fraction of
patients seek a specialist consultation and an even smaller proportion
is referred to the emergency department (ED) (Web Table 2). The
first-time incidence of syncope by age is bimodal.39–41 Its prevalence
is very high in patients aged 10–30 years, is uncommon in adults with
an average age of 40 years, and peaks again in patients aged >65 years.
In the Framingham study,40 the 10-year cumulative incidence of syn-
cope was 11% for both men and women aged 70–79 years, and 17%
and 19%, respectively, for men and women aged >_80 years. Overall,
it is estimated that approximately half of the general population will
have one syncopal event during their lifetime (Web Figure 3).
2.2.2 Prevalence of the causes of syncope
The prevalence of the causes of syncope differs depending on
the age and clinical settings in which the patient is evaluated (see
Supplementary Data Tables 1 and 2). However, some general com-
ments are possible:
• Reflex syncope is the most frequent cause of syncope in any set-
ting and at all ages.
• Cardiac syncope is the second most common cause. The num-
ber of patients with a cardiac cause varies widely between stud-
ies; higher frequencies are observed in emergency settings
mainly in older subjects, and in settings orientated towards car-
diology. Cardiac syncope is extremely rare in children, teen-
agers, and young adults.
• In patients <40 years, OH is a rare cause of syncope; it is fre-
quent in very elderly patients.
• Non-syncopal TLOC events are more frequent in emergency
referrals and reflect the multifactorial complexity of these patients.
• While reflex syncope is by far the most frequent cause of TLOC
in the young, multiple causes are often present in the elderly,
and the medical history may be less reliable than in the young.
2.3 Prognosis
2.3.1 Syncope severity
The reason for defining ‘severe syncope’ is that having such an assign-
ment can aid patient care as well as stratify patients for scientific pur-
poses. There are two reasons to label syncope as severe:
(1) The first concerns the ‘causal risk’ of syncope, i.e. the risk associated
with the underlying disease. Cardiac syncope is associated with high
morbidity and considerable mortality, meaning that any syncope
due to a proven cardiac cause is classified as severe syncope, even if
the actual episode was short-lived and had no adverse effects.
(2) The second principle concerns the ‘consequential risk’ of syncope.
This concerns the impact that syncope has on a patient’s life,
through physical trauma, disruption of school and work activity,
driving, and personal consequences:
• Physical trauma mostly occurs when there are no warning
symptoms, or these are of such a short duration that they do
not allow a patient time to take adequate action to prevent a
fall or other adverse consequence. Having suffered previous
syncope-related trauma counts strongly.
• Disruption of schooling is present when syncope causes
enough absence to cause the patient to fail grades or addi-
tional schooling is needed to prevent this from occurring.
• Work disruption occurs when the nature of the occupation
makes even a single episode hazardous, or if patients are no
longer allowed to work directly because of syncope.
• Driving: when national regulations mean that a patient with
syncope is not allowed to drive for a period of time this
counts as a substantial consequence.
• Personal consequences concern depression, as well as signifi-
cant disruption regarding the ability to take part in family activ-
ities or societal activities causing significant personal suffering.
2.3.2 Risk of death and life-threatening events
Individuals with syncope have been reported to have a 1.31 increased
risk for death from any cause, 1.27 for non-fatal myocardial infarction
or death from coronary heart disease, and 1.06 for fatal or non-fatal
stroke compared with controls.40 Several prognostic markers have
been identified (see Supplementary Data Table 3). In general:
• Poor outcomes, including death, are related to the severity of
the underlying disease rather than to syncope itself.40,42,43
• Structural heart disease44–48 is the major risk factor for sudden
cardiac death and overall mortality in patients with syncope. In
patients with severe heart failure with an implantable cardioverter
defibrillator or cardiac resynchronization therapy, syncope is
associated with appropriate defibrillator discharge and predicts a
higher mortality than similar patients without syncope.49,50
• In OH, the risk of death, coronary artery disease, heart failure,
and stroke is two-fold as high as that of the general population,
largely caused by the greater severity of comorbidities.22,51
• Conversely, young patients in whom structural or electrical
heart disease have been excluded have an excellent prognosis.40
2.3.3 Recurrence of syncope and risk of physical injury
In a recent systematic review, the incidence of syncope relapse
increased linearly from 0.3% at 30 days to 22% at 2 years of follow-up.52
....................................................................................................................................................................................................................
Web Table 2 Syncope frequency depends on the setting in which themeasurement is made Adapted fromOlde
Nordkamp et al.37 and Malasana et al.38
Setting Incidence Relative frequency
(per 1000 subject-years) (compared with 100 patients with syncope)
General population 18–40 100
Seeking any medical evaluation 9.3–9.5 25–50
Referred for specialty evaluation 3.6 10–20
Referred to emergency department 0.7–1.8 2–10
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..The number of episodes of syncope in the 1–2 years preceding clin-
ical evaluation is the strongest predictor of recurrence.53 Conversely,
sex, severity of presentation, presence of structural heart disease, and
tilt-test response have little or no predictive value.53,54
Recurrent syncope is associated with fractures and soft-tissue injury
in 12% of patients.55 In the ED, minor trauma was reported in 29.1% and
major trauma in 4.7% of cases; the highest prevalence (43%) was
observed in older patients with carotid sinus hypersensitivity.56 In the
elderly, morbidity secondary to syncope includes loss of confidence,
depression, fear of falling, fractures, and subsequent institutionalization.57
2.3.4 Risk of syncope during driving
Among patients with a history of syncope, the prevalence of recur-
rence of syncope during driving spans from 3–9.8%.58,59 The risk of
syncope-mediated car accidents is less than 1%/year.59 In highly
symptomatic subjects with VVS, the estimated risk of a severe harm
during driving was even lower than that observed in the general pop-
ulation.60 In patients with life-threatening ventricular arrhythmias
enrolled in the Antiarrhythmics versus Implantable Defibrillators
(AVID) trial,61 symptoms suggestive of tachyarrhythmia recurred fre-
quently while driving, but they were unlikely to lead to motor vehicle
accidents (0.4% per patient-year). The risk might be increased in the
2–4 months following an implantable cardioverter defibrillator shock
due to a higher probability of subsequent shocks.62 Thus, patients
with syncope are surprisingly safe to drive.
Nevertheless, a history of syncope may be regarded as an indirect
risk factor for driving accidents. Indeed, the 2-year incidence rate of
motor vehicle crashes was almost twice as high in patients with a first-
time diagnosis of syncope from an ED or hospital (2.1%/year) compared
with the general population (1.2%/year).63 Thus, syncope should be
considered as one of several factors when assessing fitness to drive.63
In conclusion, the absolute risk of driving accidents due to syncope is
low. In addressing the problem of driving resumption after a syncope
spell, physicians should first stratify the clinical risk of the patient and the
likely chance for a syncope recurrence. This applies to both private and
commercial driving independently of local driving regulations that might
Web Figure 3 Distribution of age and cumulative incidence of first episodes of syncope in the general population from subjects aged <_80 years
The data from subjects aged 5–21 years come from a study by Ganzeboom et al.39, from subjects <5 years from a study by Lombroso
and Lerman41, and from subjects aged 20–80 years from a study by Soteriades et al.40
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differentiate private from commercial driving, which may differ among
various European countries. Common principles of syncope risk stratifi-
cation may include an assessment of prodromal symptoms, frequency,
intensity, and duration, and their relationships with posture and environ-
mental conditions. Provoking factors should also be taken into account.
Several consensus documents have been published by the ESC
and other entities in the past two decades.64–70 Taking advantage of
those documents and the new literature, this Task Force proposes
the advice detailed in Web Table 3.
2.3.5 Risk of syncope during work
Syncope at work is a rare event and its impact in terms of injury is usu-
ally benign.71 However, as syncope is associated with a loss of postural
tone, even a benign vasovagal episode can be hazardous in high-risk
working environments. Thus, in people with syncope, it is necessary to
stratify the occupational risks of syncope recurrence, particularly if the
time of exposure to hazardous conditions is significant.65,72 Referral to
occupational physicians may be recommended in these circumstances.
2.4 Impact on quality of life
Recurrent syncope has effects on quality of life and the degree of
impairment is proportional to syncope frequency. In patients with six
or more lifetime syncopal spells, there was a negative relationship
between the frequency of spells and overall perception of health,
which was not evident in those with a history of fewer than six lifetime
spells.73 Adults presenting with TLOC in a tertiary syncope facility had
a worse score on all quality-of-life scales of the generic Short Form-36
than the general population. The disease-specific syncope functional
status questionnaire indicated mean impairment in 33% of the listed
activities, such as driving.74 Female sex, a high level of comorbidity, the
number of episodes of syncope, the presence of presyncope, and a
neurological or psychogenic diagnosis were associated with poorer
quality of life. Quality of life usually improves over time.75
2.5 Hospitalization and economic issues
Although a comparison of costs between studies is difficult due to dif-
ferences in methods of calculation and between healthcare systems
in different countries, it is generally believed that the management of
syncope is expensive because syncope is frequent in the general pop-
ulation, and it inevitably results in high direct clinical (i.e. the need for
multiple tests and specialist visits) and indirect social costs.76,77
In general, 1–1.5% of referrals to the ED are for syncope; of these,
about 50% are hospitalized (Supplementary Data Table 4). Hospitalization
costs account for >75% of the total costs, and most hospitalizations are
....................................................................................................................................................................................................................
Web Table 3 Advice for driving in patients with syncope
Disorder causing syncope Group 1 (private drivers) Group 2 (professional drivers)
Cardiac arrhythmias
Untreated arrhythmias Unfit to drive Unfit to drive
Cardiac arrhythmia, not life-threatening,
medical treatment
After successful treatment is established After successful treatment is established
Cardiac arrhythmia, life-threatening (e.g.
inheritable disorders), medical treatment
After successful treatment is established Permanent restriction
Pacemaker implant After 1 week After appropriate function is established
(first post-implant visit)
Catheter ablation After successful treatment is established After successful treatment is established
Implantable cardioverter defibrillator
implant
After 1 month. The risk may increase in the
few months following an implantable cardi-
overter defibrillator shock (3 months)
Permanent restriction
Structural cardiac/cardiopulmonary
After appropriate function is established After appropriate function is established
Orthostatic hypotension (neurogenic)
Syncope while sitting After successful treatment is established After successful treatment is established
Reflex syncope
Single/mild No restrictions unless it occurred during
driving
No restriction unless it occurred during
driving or without prodromes
Recurrent and severe After successful treatment is established After successful treatment is established.
Particular caution if it occurred during driv-
ing or without prodromes
Unexplained syncope
No restrictions unless absence of prodrome,
occurrence during driving, or presence of
severe structural heart disease. If yes, after diag-
nosis and appropriate therapy is established
After diagnosis and appropriate therapy is
established
Group 1: private drivers of motorcycles, cars, and other small vehicles with and without a trailer.
Group 2: professional drivers of vehicles over 3.5 tons or passenger-carrying vehicles exceeding eight seats excluding the driver. Drivers of taxicabs, small ambulances, and
other vehicles form an intermediate category between the ordinary private driver and the vocational driver and should follow local legislation.
Important remark. The observation period for the assessment of therapy efficacy should generally be longer in group 2.
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..unnecessary.78 Among the patients who present to the ED for syncope,
0.8% die and an average of 3.6% have some serious outcome within the
next 7–30 days (Supplementary Data Table 4). Therefore, only a small
minority will potentially benefit from urgent hospitalization.
One of the main objectives of a specialized syncope unit is to
reduce costs through the reduction of unnecessary hospitalizations
and the appropriate use of diagnostic tests.76 This issue is developed
in section 9 in the main manuscript.
3. Practical Instructions for
section 4.1.: initial evaluation
3.1 Medical history taking as a diagnostic
test
The medical history of a patient with TLOC can be seen as a diagnostic
test with very different test characteristics, depending on how and by
whom the information from the patient is obtained and analysed.
History taking, if properly performed, is a powerful diagnostic tool, which
in most cases proves to be the only ‘test’ necessary other than physical
examination and an electrocardiogram (ECG) in patients with TLOC.79
Assessing the efficacy of the ‘history’ as a diagnostic test has
aspects of physiological reasoning. There is no independent gold/
reference standard to diagnose syncope. As a solution to the lack of a
straightforward reference in conditions such as TLOC/syncope, dedi-
cated long-term follow-up, preferably with an expert review commit-
tee, can be used as a test of reliability of diagnosis, relying on ancillary
testing and/or additional information during follow-up, including
recurrences and health status.80,81
In one multicentre study,82 using long-term follow-up as a reference
for the yield of the initial evaluation by the attending physicians, the sum
of certain (100% certain) and highly likely (80–100% certain) initial diag-
noses ranged from 50–80%. The overall diagnostic accuracy of the initial
evaluation was also high, at 91%. Dangerous diagnoses were not missed.
3.2 Explanation of the clinical features of
transient loss of consciousness
TLOC is characterized by four specific characteristics: short duration,
abnormal motor control, loss of responsiveness, and amnesia for the
period of LOC. The specific characteristics of TLOC that aid diagno-
sis are outlined in Web Table 4:
• TLOC is certain when all four clinical features are present.
• TLOC is ruled out when any one of the following is true: motor
control was normal for the entire event, responsiveness was
intact for the entire event, or the patient has recollection of
events during the entire event.
• The absence of awareness that consciousness was lost does not
rule out TLOC.
• If there is no eyewitness, TLOC was likely present when there is
a clear gap in memory during which a fall occurred.
• A fall without amnesia is most often not TLOC; however, syn-
cope, especially in the elderly, can occur without awareness that
consciousness was lost. Presyncope in the elderly may cause falls.
The criteria for TLOC are based exclusively on the patient’s history
and eyewitness accounts because such events are usually not wit-
nessed by medically trained persons. As the diagnosis of TLOC is based
on history taking and not on an examination at the time, the criteria
cannot ensure that consciousness was truly lost, only that it appeared
lost. Hence, TLOC includes disorders with a somatic LOC, i.e. syncope
and epileptic seizures, as well as their psychogenic mimics. Syncope,
mostly due to VVS, vastly outnumbers the other conditions.
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
Web Table 4 Explanation of the clinical features of transient loss of consciousnessa
Clinical feature Comments
Short duration of LOCb Based on often-unreliable accounts from the patient and eyewitness
• When measured reliably, a duration of 5 minutes represents the limit of TLOC
• When estimated, longer times may be mentioned
Abnormal motor control Fall requires both patient history and eyewitness accounts:
• Fall (loss of postural control)c
• Abnormal high (stiff) or low (flaccid) muscle tone
• Absence of normal limb movement
• Presence of abnormal movement
• A fall is more likely due to LOC if there is no recollection of the fall itself and
no evidence of protective measures such as extending the hands.
The other aspects of motor control require an eyewitness account:
• Stiffness and flaccidity are apparent from the way of falling and the posture once supine;
limb, neck, or trunk muscle tone can be felt by eyewitness
• Absence of normal movement is established through observation
• Abnormal movements may include muscle jerks, abnormal posture of limbs,
the face or head, the breathing pattern, eye opening, making sounds or incontinence
Loss of responsiveness Requires action by an eyewitness
• No response to speech
• No or abnormal response to touch or pain
Amnesia for period of unconsciousness Requires patient history (sometimes eyewitness account)
LOC = loss of consciousness; TLOC = transient loss of consciousness.
a‘Transient’ implies that the features of transient loss of consciousness resolve completely.
bA short duration here concerns motor elements, amnesia, and responsiveness only; concomitant symptoms such as fatigue or sleepiness may last for much longer periods.
cA fall cannot be assessed when a patient is already supine or when circumstances prevented falling, such as sitting in a car or armchair. A fall on its own does not guarantee loss
of consciousness.
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4. European Society of Cardiology
guideline checklists of historical
clues to diagnose transient loss of
consciouness
The items listed in the five tables below have been gathered from sev-
eral sources. Note that for most of the items, not enough information
is available to evaluate their utility in terms of sensitivity and specific-
ity. This scheme assumes the classification of TLOC as used by the
ESC.
4.1 Triggers before the attack
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
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....................................................................................................................................................................................................................
Web Table 5.1 Checklists of historical clues to diagnose transient loss of consciousness
Historical clue Possible diagnosis References, comments, definition
Supine position (awake) - Cardioinhibitory VVS through pain or fear Epilepsy83
- Arrhythmia Cardiac84
- PPS and PNES
During normal sleep - Epilepsy Epilepsy83,85
- Arrhythmia Sleep syncope86,87
- If prodrome of VVS causing awakening þ syncope thereafter:
“sleep syncope”
Sitting - All causes (including “orthostatic VVS” and classical OH) For VVS88,89
Standing for some period - All causes
- If TLOC occurs only while standing: OH, orthostatic VVS
Couple of steps after standing up or straight-
ening from bending or squatting position
Initial OH and classical OH Initial OH90
Micturition, defaecation Situational reflex syncope (note: defaecation and diarrhoea
may act as triggers for VVS but also as symptoms of VVS)
Micturition91–93
Defaecation93,94
Coughing Situational syncope (usually prolonged intensive coughing,
often in smokers with lung disease)
95–98
Swallowing Situational syncope (usually oesophageal disease) 99
Laughing out loud, telling jokes, unexpect-
edly meeting an acquaintance
Cataplexy (ask about excessive daytime sleepiness) 100
Laughter Situational reflex syncope (very rare) 101,102
During and after eating - All causes (a specific circumstance)- Only during/after eating
(15 minutes): postprandial hypotension, particularly in the eld-
erly and with autonomic failure- If preferentially during meals:
arrhythmia/Brugada syndrome
Postprandial hypotension103,104
Head movements, pressure on the neck,
shaving
Spontaneous type of carotid sinus syncope 105
Fear, pain, instrumentation Classical VVS 90
During physical exercise - Cardiac structural- Cardiac arrhythmic: AV block, LQTS1,
catecholaminergic VT- May occur in autonomic failure- VVS
in very young/teenagers
Effort84
Directly after cessation of physical exercise - Post-exercise hypotension in middle-aged and elderly people:
autonomic failure
AF106,107
- Young people: VVS, particularly in trained athletes VVS108,109
During arm exercise Steal syndrome (very rare) 110
Palpitations - Cardiac: tachyarrhythmia 111
- Postural tachycardia in VVS, POTS Syncope vs. seizure112
Strong emotions other than fear (e.g.
argument)
- Cataplexy Cataplexy100
- Arrhythmia: catecholaminergic polymorphic VT; also during
exercise, in children and young adults
Catecholaminergic polymorphic VT113,114
Startling (e.g. alarm clock) - LQTS2 LQTS2115
- Startle epilepsy Epilepsy116
During fever - VVS (more often) Many case reports but no systematic
counts on syncope with/without fever- Brugada syndrome
Flashing lights Epilepsy with photosensitivity 117,118
Sleep deprivation - Epilepsy Epilepsy83,119
- VVS
Heat/warmth/hot bath - VVS VVS39
- Classical OH OH120,121
Syncope vs. seizure112
AF = atrial fibrillation; AV = atrioventricular; LQTS = long QT syndrome; OH = orthostatic hypotension; PNES = psychogenic non-epileptic seizures; POTS = postural ortho-
static tachycardia syndrome; PPS = psychogenic pseudosyncope; TLOC = transient loss of consciousness; VT = ventricular tachycardia; VVS = vasovagal syncope.
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4.2 At the onset of the attack
4.3 During the attack (eyewitness account)
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
Web Table 5.2 Checklists of historical clues to diagnose transient loss of consciousness: at the onset of the attack
Historical clue Possible diagnosis References, comments, definition
Change in vision: seeing dark spots, loss of colour vision
(rare).Change in hearing: sounds coming as if from a dis-
tance, buzzing or ringing in the ears
Syncope: symptoms of cerebral hypoperfu-
sion, so not related to cause of syncope
122
Nausea, sweating, pallor Reflex syncope: autonomic activation Sweating (syncope vs. epilepsy)112
Pain in shoulders and neck (“coat hanger pattern”) Classical OH: ischaemia of local muscles 123,124
Shout at onset of attack (“ictal cry”) Epilepsy 125
Rising sensation from abdomen - Epileptic aura Epilepsy126
- Rising abdominal sensation occurs in VVS,
not often
VVS122
Rising sensation from abdomen, unpleasant smell or taste, or
other phenomena specific to subject but recurring in attacks
Epileptic aura 127,128
De´ja vu/jamais vu (pro seizure)112
OH = orthostatic hypotension; VVS = vasovagal syncope.
....................................................................................................................................................................................................................
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Web Table 5.3 Checklists of historical clues to diagnose transient loss of consciousness: during the attack
(eyewitness account)
Historical clue Possible diagnosis References, comments, definition
Fall:
Keeling over, stiff - Tonic phase epilepsy 129
- Syncope less often (all causes)
Flaccid collapse - Syncope (all variants) 129
- Atonic epilepsy (rare, children) Atonic seizures130
Movementsa:
Mere presence: limited utility for differentiating syncope from epilepsy; details needed
Beginning before the fall (partial, one-sided) Epilepsy -
Beginning after the fall - Epilepsy -
- Syncope
Symmetrical, synchronous Epilepsy -
Asymmetrical, asynchronous Syncope, may rarely be epilepsy -
Beginning at onset of unconsciousness - Epilepsy Syncope3
- Syncope (usually some seconds later)
Beginning after onset of LOC Syncope Syncope3 (mean 20 seconds)
Duration LOC <30 seconds If measured, syncope far more likely than
epilepsy
Seizure: mean 74 seconds,131 mean 90
seconds132
Syncope3
Duration of LOC >1 minute - If measured, epileptic seizure more likely than
syncope
Seizure131
- PNES Syncope3
Duration of LOC >5 minutes - PPS PNES vs. seizure85,133,134
- PNES PPS135
Few movements (10 or so) Syncope far more likely than epilepsy
Many movements (“100”, “cannot count”) - Epilepsy
- PNES
Restricted to one limb or one side - Epilepsy -
- Syncope
Pelvic thrusting - PNES 136,137
- Frontal lobe seizures, rare in temporal lobe
seizures
In children: very rare134
Repeated waxing and waning in intensity and
changes in nature of movement
PNES 85
LOC = loss of consciousness; PNES = psychogenic non-epileptic seizures; PPS = psychogenic pseudosyncope.
aThe word “clonic” is in everyday use restricted to epilepsy, while the word “myoclonus” is used for the movements in syncope as well as for certain types of epilepsy and to
describe postanoxic movements. The word “convulsions” is best reserved for epilepsy. “Myoclonic jerks” has little connotation with a specific cause, and it is preferable to avoid
making unwarranted conclusions.
ESC Guidelines e57
D
ow
nloaded from
 https://academ
ic.oup.com
/eurheartj/article-abstract/39/21/e43/4939242 by Azienda O
spedaliera C
areggi user on 28 D
ecem
ber 2018
4.4 Other aspects
4.5 After the attack
....................................................................................................................................................................................................................
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Web Table 5.4 Checklists of historical clues to diagnose transient loss of consciousness: other aspects
Historical clue Possible diagnosis References, comments, definition
Oral automatisms (chewing,
smacking, blinking)
- Epilepsy Syncope3
- Syncope (often, but very rarely noticed)
Cyanotic face - Epilepsy VVS vs. arrhythmic syncope138
-Cardiac syncope
Eyes open -Epilepsy seizure vs. PNES139
-Syncope (only closed in shallow and short-lasting syncope)
Eyes closed during
unconsciousness
-PPS PPS135
-PNES PNES140–142
-Concussion
Tongue bitten -Epilepsy more likely than syncope if lateral side of tongue (uni- or bilateral) Trauma143
-Syncope very rare, then tip of tongue Epilepsy vs. syncope112,144,145
-Does not differentiate PNES from epilepsy Epilepsy vs. PNES146
-Accidental falls can also cause tongue laceration
Urinary incontinence Does not differentiate epileptic seizures and syncope, nor epileptic seiz-
ures and psychogenic TLOC
147
Paresis, ataxia, brain stem signs Vertebrobasilar TIA 148
Sterterous (snoring) breathing -Epileptic seizure more likely than PNES Seizure85
-Syncope only short (10 seconds) in deep hypoperfusion Syncope3
Head turning -Epileptic seizures (prolonged) Syncope vs. seizure3,112
-Syncope with deep hypoperfusion (<30 seconds)
Sudden severe headache. Later
vomiting, nuchal rigidity
Subarachnoid haemorrhage 149
Apparent LOC lasts 10–30
minutes
-Not TLOC! 135
-PNES or PPS (more properly “pseudocoma”)
-LOC due to trauma, metabolic causes, etc.
Eye fluttering PNES more likely than epileptic seizure 139
Bruises and other injuries All causes (including PPS, PNES) PNES150
LOC = loss of consciousness; PNES = psychogenic non-epileptic seizures; PPS = psychogenic pseudosyncope; TIA = transient ischaemic attack; TLOC = transient loss of con-
sciousness; VVS = vasovagal syncope.
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Web Table 5.5 Checklists of historical clues to diagnose transient loss of consciousness: after the attack
Historical clue Possible diagnosis References, comments, definition
Nausea, sweating, pallor -Reflex syncope: autonomic activation -
-Also stress response to TLOC of any cause
Clear-headed immediately on regaining consciousness -Syncope -
-Epilepsy (extremely rare)
Disorientated and amazed for 5–10 seconds,
memory restored at once afterwards
Syncope (typical, often not noted) 3
Confused, with memory problems for many minutes
after regaining consciousness
Epilepsy 112
Sleep -Epilepsy (initially stupor) 151
-Reflex syncope (voluntary sleep, particularly children)
Aching muscles (not due to bruises) Epilepsy, but also PNES 152
Chest pain Cardiac: ischaemia 153
Crying -Infants: all causes PNES85
PNES = psychogenic non-epileptic seizures; PPS = psychogenic pseudosyncope; TLOC = transient loss of consciousness.
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4.6 Antecedent disorders
5. Practical Instructions for
section 4.2.1.: carotid sinus
massage
The current definition of carotid sinus syncope requires the repro-
duction of syncope, i.e. the so-called ‘method of symptoms’,168–172
in addition to the documentation of abnormal cardioinhibitory and/or
vasodepressor reflex:
• Carotid sinus massage (CSM) is preferably performed during
continuous ECG and non-invasive beat-to-beat BP monitoring.
• CSM consists of manual compression with the tips of the sec-
ond, third, and fourth fingers of one hand at the site of the maxi-
mum carotid pulse,173 between the angle of the jaw and the
cricoid cartilage on the anterior margin of the sternocleidomas-
toid muscle, with the face rotated contralaterally. The massage
is applied up and down the carotid artery on the right and then
on the left side in the supine position, and then in the upright
position for 10 s in each position, to allow symptoms to develop;
the time between massages has to be long enough to allow HR
and BP values to return to baseline. Thus, each patient under-
goes up to four massages.
• Even if an asystolic pause is evoked by CSM, the possibility still
exists that the patient may also exhibit a marked vasodepressor
response. To assess the contribution of the vasodepressor com-
ponent (which may otherwise be hidden), CSM is repeated after
intravenous administration of 0.02 mg/kg of atropine. Atropine
eliminates vagally induced asystolic pauses, thereby unmasking
vasodepressor response.
• Carotid sinus hypersensitivity is diagnosed when CSM elicits
abnormal cardioinhibition (i.e. asystole >_3 s) and/or vasodepres-
sion (i.e. a fall in systolic BP >50 mmHg) (Web Figure 4). Carotid
sinus syncope is established when spontaneous symptoms (syn-
cope or presyncope) are reproduced in the presence of
....................................................................................................................................................................................................................
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....................................................................................................................................................................................................................
Web Table 5.6 Checklists of historical clues to diagnose transient loss of consciousness: antecedent disorders
Historical clue Possible diagnosis References, comments,
definition
Recent start or change of medication -VVS (volume depletion, antihypertensives)
-OH
-Arrhythmia (long QT)
History of heart disease -Cardiac: arrhythmia or structural -
Hypertension -OH due to medication
-OH in autonomic failure (if BP only measured supine or sitting)
Parkinsonism OH (autonomic failure: Parkinson’s disease, multiple system atrophy) 154,155
Impotence and micturition
problems for a few years
If OH present: autonomic failure 31
Orthostatic intolerance -VVS By definition
-OH
-POTS
History of epilepsy Epilepsy -
Structural brain damage Epilepsy -
Earlier possibly traumatizing events -PNES 156
-PPS (not obligatory!)
-Other coincidental causes
Earlier psychosis, depression OH due to antidepressive or antipsychotic drugs 157–160
Sudden death in family members
<40 years of age
Genetic arrhythmia / cardiomyopathy / thoracic aortic dissection 161,162
Diabetes mellitus - Cardiac syncope OH163
- OH (secondary autonomic failure)
- (LOC due to hypoglycaemia: too long for TLOC)
Earlier VVS before 35 years of age VVS more likely than arrhythmic syncope 138
No syncope before 35 years of age VVS less likely VT vs. VVS164
Family history of VVS VVS much more likely (but background rate is one-third of population) 165–167
Recognition similar to VVS in youth VVS much more likely -
BP = blood pressure; LOC = loss of consciousness; OH = orthostatic hypotension; PNES = psychogenic non-epileptic seizures; POTS = postural orthostatic tachycardia syn-
drome; PPS = psychogenic pseudosyncope; TLOC = transient loss of consciousness; VT = ventricular tachycardia; VVS = vasovagal syncope.
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..bradycardia (usually >6 s) and/or hypotension. The isolated vas-
odepressor form is defined when CSM reproduces symptoms
with a fall in systolic BP during at least one massage in the
absence of asystole >_3 s. In patients who have baseline asystole
>_3 s, the mixed form is diagnosed when symptoms persist after
the elimination of asystole by means of atropine (Web Figure 5).
In patients who have baseline asystole >_3 s, the cardioinhibitory
form is diagnosed when symptoms disappear after the elimina-
tion of asystole by means of atropine (Web Figure 6).
6. Practical Instructions for
section 4.2.2.2: tilt testing
6.1 Method of tilt testing
It is recommended that the following method is adopted:174–181
• Patients should be fasted for 2–4 h before the test.
• Ensure a supine pre-tilt phase of >_5 min when there is no
venous cannulation, and of >_20 min when there is venous
cannulation.
• Tilt angle between 60o and 70o.
• Passive phase of tilt of >_20 min duration and a maximum of
45 min.
• Use either sublingual nitroglycerin or intravenous isoproterenol
for drug provocation if the passive phase is negative. The dura-
tion of the drug-challenge phase is 15–20 min:
• for nitroglycerin challenge, a fixed dose of 300–400 lg sublin-
gually administered with the patient in the upright position;
• for isoproterenol challenge, an incremental infusion rate from
1 lg/min rising to 3 lg/min to increase average HR by about
20–25% over baseline.
• The test should be continued until complete LOC occurs or
completion of the protocol.
• Tilt tables have only one specific requirement: the tilt-down
time should be short (<15 s) as longer times increase the dura-
tion of precipitated asystole.
Tilt testing is safe. There have been no reported deaths during the
test. However, some rare life-threatening ventricular arrhythmias
with isoproterenol in the presence of ischaemic heart disease have
been reported.182 No major complications have been published with
the use of nitroglycerin. Minor side effects are common, and include
palpitations with isoproterenol and headache with nitroglycerin.
Atrial fibrillation can be induced during or after a positive tilt test and
is usually self-limited.34,183 Contraindications to the administration of
isoproterenol include ischaemic heart disease, uncontrolled hyper-
tension, LV outflow-tract obstruction, and significant aortic stenosis;
caution should be used in patients with known arrhythmias.
6.2 Classification of positive responses
In general, the vasovagal reaction lasts roughly 3 min or less before
causing LOC.180,184 A decrease in systolic BP to <90 mmHg is associ-
ated with symptoms of impending syncope185,186 and to <60 mmHg is
associated with syncope.3,185 Prodromal symptoms are present in vir-
tually all cases of tilt-induced VVS, which occurs, on average, 1 min
after the onset of prodromal symptoms.185,186 During the prodromal
phase, BP falls markedly; this fall frequently precedes the decrease in
HR, which may be absent at least at the beginning of this
phase.180,185,186 Web Figure 7 shows the main events observed in tilt-
induced reflex syncope based on the mean of 69 tests.3 Web Videos 1A
and 1B (see Supplementary material online, Video 1A and 1B.) show
clinical phenomena in relation to circulatory changes (plus EEG).
The temporal relationship between asystolic pause and LOC—
assessed by means of video monitoring—has shown that an asystolic
pause precedes LOC for 3–12 s in two-thirds of patients, whereas
asystolic pause coincides or follows LOC in the others.187 This find-
ing might have practical implications for pacemaker therapy.
Web Figure 4 Method of symptoms: classification of responses. BP = blood pressure; CI = cardioinhibitory; CSH = carotid sinus hypersensitivity;
CSM = carotid sinus massage; CSS = carotid sinus syncope; VD = vasodepressor reflex.
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Web Figure 5 Mixed form of carotid sinus syndrome diagnosed by carotid sinus massage performed according to the ‘method of symptoms’.
Baseline (upper panel). The massage was performed during beat-to-beat, electrocardiograph (top trace), and systolic blood pressure (bottom trace)
monitoring, with the patient on a tilt table in the upright 60 position. Arrows indicate the time of the beginning and end of massage, which was contin-
ued for 10 s. A 9.6-s asystole was induced soon after the beginning of the massage. The mean circulatory filling pressure decreased to approximately
<40 mmHg after 10 s of carotid sinus massage; this was insufficient to preserve brain perfusion and caused syncope. Atropine (lower panel). To deter-
mine the relative contribution of the two components of the reflex, the cardioinhibitory component was suppressed by means of intravenous infusion
of 0.02 mg/kg atropine and the massage was repeated. Systolic blood pressure fell to approximately 75 mmHg and the patient again had syncope after
approximately 15 s. The vasodepressor component of the reflex, as well as the asystolic reflex, was therefore a major determinant of syncope in this
patient, justifying classification as a mixed form. BP = blood pressure; CSM = carotid sinus massage; i.v. = intravenous; “ = seconds; L = lead.
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Web Figure 6 Dominant cardioinhibitory form of carotid sinus syndrome diagnosed by carotid sinus massage performed according to the
‘method of symptoms’. Baseline (upper panel). The massage was performed during beat-to-beat, electrocardiographic (top trace), and systemic BP
monitoring (bottom trace), with the patient on a tilt table in the upright 60 position. Arrows indicate the time of the beginning and end of massage,
which was continued for 10 s. A 6.2-s asystole was induced soon after the beginning of the massage. The mean circulatory filling pressure decreased
to approximately 55 mmHg after 8 s of carotid sinus massage; this was insufficient to preserve brain perfusion and caused syncope. The vasodepres-
sor reflex persisted longer than the cardioinhibitory reflex, with recovery to baseline values after 23 s. Atropine (lower panel). To determine the
relative contribution of the two components of the reflex, the cardioinhibitory component was suppressed by means of intravenous infusion of
0.02 mg/kg atropine and the massage was repeated. Although systolic blood pressure fell to approximately 85 mmHg, syncope could not be repro-
duced, thus showing that the cardioinhibitory component of the reflex was the main determinant of syncope in this patient. BP = blood pressure;
CSM = carotid sinus massage; i.v. intravenous; “ = seconds; L = lead.
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6.3 Patterns of tilt table test results
In the following figures, BP is shown in the bottom panel with
separate lines for systolic and diastolic BP, expressed in mmHg. In
the top panel, HR is shown as b.p.m. Time is indicated in minutes
and axis ticks indicate 5 min. Results are first shown as schematic
images, followed by example results. The example results are scaled
to ensure that the scales for BP, HR, and time are the same in all
figures.
6.3.1 Normal tilt table test results
After head-up tilt, no change in BP or a slight increase of <_10% occurs
(Web Figure 8). HR increases by <_10% until patients are tilted back
again.
6.3.2 Pattern of tilt-induced reflex syncope
At variable times after head-up tilt, BP starts to decrease slowly and
slightly for several minutes (Web Figure 9). The rate of BP drop then
increases, resulting in a ‘convex’ curve. HR usually increases gradually
and slightly before syncope during tilt. HR then decreases, represent-
ing cardioinhibition. This decrease usually starts later than the BP
decrease. The HR decrease, like BP, shows an increasing rate of drop.
HR also decreases slightly in pure vasodepressive syncope. After tilt-
ing back, HR and BP increase quickly again. The core features of reflex
syncope differentiating it from OH are a latency after head-up tilt, a
‘convex’ BP decrease, and a decrease in HR.
6.3.3 Example #1 of reflex syncope
Note that the slow and slight decrease in BP occurs well before the
BP decreases quickly (Web Figure 10). In this case, there is a limited
HR decrease.
6.3.4 Example #2 of reflex syncope
Here, HR increases briefly when BP starts to decrease, but this
makes way for a very steep decrease in HR, ending in asystole (Web
Figure 11).
Heart rate
Mean 
blood 
pressure
EEG 
slow/flat
TLOC
Begin clinical
TLOC
Time (s.)
b.p.m
mmHg
Web Figure 7 Main events observed in tilt-induced reflex syn-
cope based on the mean of 69 tests.3 Smoothed mean arterial blood
pressure (blue line) and heart rate (red line) are shown. The shaded
areas indicate mean ± 1 standard error. Data were centred around
the clinically established onset of loss of consciousness (t= 0).
Clinical loss of consciousness (grey line) shows how many subjects
were unconscious as a function of time. Electroencephalogram
(orange line) shows how many subjects had electroencephalogram
changes (slow or flat) as a function of time. The vertical axis indi-
cates mmHg for blood pressure, b.p.m. for heart rate, and numbers
for the histograms. BP = blood pressure; b.p.m. = beats per minute;
EEG = electroencephalogram; HR = heart rate; LOC = loss of con-
sciousness; TLOC = transient loss of consciousness.
Web Figure 8 Normal tilt table test result. BP = blood pres-
sure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 9 Pattern of tilt-induced reflex syncope. BP =
blood pressure; b.p.m. = beats per minute; HR = heart rate.
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6.3.5 Example #3 of reflex syncope
In some cases, hardly any changes in BP or HR are seen before the
accelerating decrease in BP causing syncope (Web Figure 12). Here,
HR decreased along with BP, resulting in asystole (expanded in the
bottom panel).
6.3.6 Pattern of classical orthostatic hypotension
Directly after head-up tilt, BP starts to decrease, with a decreasing
rate of drop resulting in a ‘concave’ curve (Web Figure 13). BP may
stabilize at a lower level or may continue to decrease during head-up
tilt. The criteria for the systolic BP decrease used to recognize classi-
cal OH are indicated with a rectangle.
Note that after the first 3 min, BP may decrease considerably. If
HR control is functional, HR will increase in an attempt to
Web Figure 10 Example of result of tilt-induced reflex syn-
cope. BP = blood pressure; b.p.m. = beats per minute; HR = heart
rate.
Web Figure 11 Example of reflex syncope. BP = blood pres-
sure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 12 Example of reflex syncope. BP = blood pres-
sure; b.p.m. = beats per minute; ECG = electrocardiogram, lead II;
HR = heart rate.
Web Figure 13 Pattern of classical orthostatic hypotension. BP
= blood pressure; b.p.m. = beats per minute; HR = heart rate.
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compensate for low BP. IF HR control is severely impaired, HR will
not increase or only very little, and usually will not vary much
between beats. The hallmarks of classical OH are no BP latency after
head-up tilt, a (upwards) concave shape of the decrease, and if HR
changes, it increases.
6.3.7 Example #1 of classical orthostatic hypotension
Note the concave shape of the BP curve and the lack of a significant
HR increase: the lack of HR variability indicates impaired HR control
(Web Figure 14). The recording was taken from a subject with neuro-
genic OH. Supine BP is high, which is common in neurogenic OH.
6.3.8 Example #2 of classical orthostatic hypotension
Supine BP is high in this patient with neurogenic OH (Web Figure 15).
In contrast to the previous example, HR can still increase.
6.3.9 Pattern of delayed orthostatic hypotension
The shape of the decrease of HR and BP is more variable in delayed
OH than in classical OH, and the rate of decrease may vary (Web
Figure 16). The degree of HR compensation also varies.
6.3.10 Example of delayed orthostatic hypotension
In this example, BP decreases slightly in the first 3 min, but not
enough to meet the demands for classical OH (Web Figure 17). In this
Web Figure 14 Example of classical orthostatic hypotension.
BP = blood pressure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 15 Example of classical orthostatic hypotension.
BP = blood pressure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 16 Pattern of delayed orthostatic hypotension. BP
= blood pressure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 17 Example of delayed orthostatic hypotension.
BP = blood pressure; b.p.m. = beats per minute; HR = heart rate.
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patient, this is followed by a slow decrease and finally a response that
is reminiscent of reflex syncope.
6.3.11 Pattern of psychogenic pseudosyncope
PPS occurs with a variable interval after head-up tilt. However, it may
occur within 1 or 2 min of head-up tilt (Web Figure 18). There are no
decreases in BP and HR; usually both BP and HR increase several
minutes before the event, reaching peak values during it.
6.3.12 Example of psychogenic pseudosyncope
In this example, BP and HR start to increase about 2 min after head-
up tilt and a clinical event occurred almost 5 min after head-up tilt
(Web Figure 19). The marked variability in HR and BP after the event
in this case was due to emotional upset.
6.3.13 Pattern of postural orthostatic tachycardia
syndrome
The HR criteria for POTS are indicated by a rectangle (Web
Figure 20). POTS can only be diagnosed in the absence of OH.
6.3.14 Example of postural orthostatic tachycardia
syndrome
In this example, BP and HR increase quickly at first and then gradually
keep increasing over about 15 min (Web Figure 21). There is no OH.
Web Figure 19 Example of psychogenic pseudosyncope. BP =
blood pressure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 18 Pattern of psychogenic pseudosyncope. BP =
blood pressure; b.p.m. = beats per minute; HR = heart rate.
Web Figure 20 Pattern of postural orthostatic tachycardia syn-
drome. BP = blood pressure; b.p.m. = beats per minute; HR = heart
rate.
Web Figure 21 Example of postural orthostatic tachycardia
syndrome. BP = blood pressure; b.p.m. = beats per minute; HR =
heart rate.
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..6.3.15 Example of video recording of reflex syncope
See Supplementary material online, Video 1A and 1B.
7. Practical Instructions for
section 4.2.3: basic autonomic
function tests
7.1 Method for performing and
interpreting autonomic function tests
properly
Autonomic function assessment, performed in a dedicated labora-
tory, aims to characterize cardiovascular sympathetic and parasympa-
thetic autonomic function, and may identify autonomic failure as the
underlying cause of syncope. No single autonomic function test can
provide a comprehensive assessment of the autonomic nervous sys-
tem, so different clinical questions may require a different battery of
autonomic function tests.
Autonomic function testing should be performed by a specialist
trained in autonomic function testing and interpretation. The required
equipment includes beat-to-beat BP and ECG monitoring, a motorized
tilt table, 24-h ambulatory BP monitoring devices, and other specialized
equipment depending on the range of testing. Tests should ideally be
performed before noon in a quiet environment. The room should be
temperature controlled, between 21–23C. Patients should be fasted
for 3 h before the test, and avoid nicotine and caffeine-, theine-, or
taurine-containing drinks on the day of examination.
7.1.1 Valsalva manoeuvre
The four phases of the Valsalva manoeuvre are illustrated in Web
Figure 22A and 22B. During the manoeuvre, the patient is asked to
conduct a maximally forced expiration for 15 s against a closed glot-
tis, i.e. with closed nose and mouth, or into a closed loop system with
a resistance of 40 mmHg. The haemodynamic changes during the test
should be monitored using beat-to-beat continuous non-invasive BP
measurement and ECG. In the initial phase (phase I, first 2–3 s), BP
slightly increases due to temporarily increased left ventricle filling.
When intrathoracic pressure rises during the forced expiration
(phase II), BP decreases due to strongly reduced venous return in
normal individuals, cardiac output declines, and a compensatory HR
increase occurs driven by the baroreceptor reflex. The hypotension
evokes another autonomic compensatory response, i.e. an increase
in the systemic vascular resistance (total peripheral resistance) driven
by the sympathetic outflow to the vessels. Thus, both HR increase
and vasoconstriction counteract hypotension. Finally, when the
patient releases the air (phase III) and starts breathing normally
(phase IV), the intrathoracic overpressure suddenly declines and a
typical ‘overshoot’ in BP can be observed, while the HR normalizes.
I
II
II_L
III
IV
 Healthy subject Patient with AF
BP
HR
A B
Web Figure 22 Valsalva manoeuvre. (A) The four phases of a normal Valsalva response in a healthy subject. Phase I: the patient begins to inflate their
lungs. Intra-thoracic pressure rises and transiently increases cardiac stroke volume (mechanical effect). Phase II: initially, a distinct blood pressure fall can
be observed, as intrathoracic pressure increases and the venous return declines (early phase II); sympathetic outflow to the blood vessels increases and
parasympathetic outflow to the heart decreases in late phase II. Phase III: the patient stops inflating their lungs; blood pressure falls briefly (mechanical
effect, mirror of phase I). Phase IV: intrathoracic pressure returns to negative and enhances venous return to the heart; sympathetic vasoconstriction pro-
duces blood pressure ‘overshoot’, confirming preserved autonomic control of the cardiovascular system. Parasympathetic effect on the heart is rate
decrease. (B) Pathological Valsalva response in autonomic failure. Absence of heart rate increase (phase II) and delayed blood pressure recovery (phase
IV) are characteristic of cardiovascular autonomic denervation. AF = autonomic failure; BP = blood pressure; HR = heart rate.
ESC Guidelines e67
D
ow
nloaded from
 https://academ
ic.oup.com
/eurheartj/article-abstract/39/21/e43/4939242 by Azienda O
spedaliera C
areggi user on 28 D
ecem
ber 2018
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
.
A case of normal Valsalva response is shown in Web Figure 23A.
A case of pathological Valsalva response in autonomic failure is
shown in Web Figure 23B. Absence of heart rate increase (phase II)
and delayed blood pressure recovery (phase IV) are characteristics of
cardiovascular autonomic denervation.
A case of pronounced hypotensive Valsalva response in situational
syncope is shown in Web Figure 24.
7.1.1.1 Example of video recording of Valsalva manoeuvre
See Supplementary material online, Video 2. With thanks to Dr. Jean
Pierre Ndayisaba, Innsbruck, A who contributed to Video production.
7.1.2 Deep-breathing test
During the deep-breathing test, the patient is asked to breathe deeply
at 6 breaths per minute for 1 min under continuous HR and BP moni-
toring. In healthy individuals, HR rises during inspiration and falls dur-
ing expiration (Web Figure 25A and Web Video 3, see Supplementary
material online, Video 3). This phenomenon, known as respiratory
sinus arrhythmia, is modulated by cardiac parasympathetic (vagal)
outflow. Similar fluctuations can be observed in BP, cardiac output,
and total peripheral resistance. These oscillations are mechanically
induced by the changes in transthoracic pressure produced by rhyth-
mic respiratory activity. HR variability during deep breathing (also
called the expiratory/inspiratory index, or E/I index) is >_15 b.p.m. in
healthy individuals aged >50 years. In patients with cardiovascular
autonomic failure (Web Figure 25B), HR variability during deep
breathing is blunted or even abolished due to degeneration of para-
sympathetic autonomic fibres to the heart. The absence of vascular
sympathetic modulation can be inferred by the lack of oscillation in
total peripheral resistance, whereas non-neural respiratory mediated
fluctuations can be observed in BP and cardiac output.
7.1.2.1 Example of video recording of deep-breathing test
See Supplementary material online, Video 3. With thanks to Dr. Jean
Pierre Ndayisaba, Innsbruck, A who contributed to Video
production.
Web Figure 23 Valsalva response. (A) Normal Valsalva response: initially, a distinct blood pressure fall can be observed as intrathoracic
pressure increases and venous return declines (phase II). Reflex heart rate increase and vasoconstriction produce blood pressure ‘overshoot’ in late
phase II and phase IV, confirming preserved autonomic control of the cardiovascular system. (B) Pathological Valsalva response in autonomic failure.
Absence of HR increase (phase II) and delayed BP recovery (phase IV) are characteristic of cardiovascular autonomic denervation. BP = blood
pressure; CO = cardiac output; ECG = electrocardiogram; exp = expiration; HR = heart rate; ins = inspiration; RESP = respiration; TPR = total
peripheral resistance.
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Web Figure 24 Pronounced hypotensive Valsalva response in situational syncope (cough, weightlifting, brass instrument playing, or singing).
Normal heart rate response (1) is associated with a pronounced hypotension (2) and reproducible subjective symptoms (dizziness). BP = blood pres-
sure; b.p.m. = beats per minute; Dia = diastolic; HF = heart failure; HR = heart rate; MAP = mean arterial pressure; Sys = systolic.
Web Figure 25 Deep-breathing test. (A) Deep-breathing test in a 59-year-old healthy proband. Note preserved heart rate modulation during
the test. (B) Deep-breathing test in a 62-year-old patient with pure autonomic failure atrophy. Note that heart rate variability during the test is almost
abolished. BP = blood pressure; CO = cardiac output; ECG = electrocardiogram; exp = expiration; HR = heart rate; ins = inspiration; RESP = respira-
tion; TPR = total peripheral resistance.
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7.1.3 Twenty-four-hour ambulatory blood pressure
In patients with autonomic failure, OH is frequently associated with a nocturnal ‘non-dipping’ or even ‘reverse-dipping’ BP pattern (Web Figure 26).
Web Figure 26 Nocturnal blood pressure patterns in 24-h ambulatory blood pressure monitoring. (A) Dipping (blood pressure falls >10% with
respect to daytime). (B) Non-dipping (blood pressure falls <10% with respect to daytime). (C) Reverse dipping (BP increases with respect to day-
time). Note exacerbation of hypotension in the early morning and after meals (at 2 p.m. and 8 p.m.) in this 57-year-old patient with multiple system
atrophy. Reproduced from Fanciulli et al., 2014188 with permission from Springer Verlag Wien. BP = blood pressure; diast. = diastolic; F = failed measure-
ment; HR = heart rate; M = manual measurement; syst. = systolic.
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8. Practical Instructions for section 4.2.4.7: implantable loop recorder
8.1 Classification of electrocardiographic recordings
Figures taken from Brignole et al.189,190
8.1.1 Type 1A, sinus arrest 8.1.2 Type 1B, sinus bradycardia plus atrioventricular block
....................................................................................................................................................................................................................
Web Table 6 Classification of electrocardiogram recordings with their probable related pathophysiology (adapted
from the International Study on Syncope of Unknown Etiology classification)189–191
Type ECG classification Suggested pathophysiology
Type 1. Asystole (R-R pause >_3
seconds)
Type 1A. Sinus arrest: progressive sinus bradycardia or initial sinus tachycardia fol-
lowed by progressive sinus bradycardia until sinus arrest (see Web Figure 27)
Probably reflex
Type 1B. Sinus bradycardia plus AV block: progressive sinus bradycardia followed
by AV block (and ventricular pause/s) with concomitant decrease in sinus rate
(see Web Figure 28)
Probably reflex
Type 1C. AV block: sudden onset AV block (and ventricular pause/s) with concomi-
tant increase in sinus rate (see Web Figures 29 and 30)
Probably intrinsic (if SHD or
bundle branch block) or
idiopathic (if no SHD and low
plasmatic adenosine)190
Type 2. Bradycardia Decrease in HR >30% or <40 b.p.m. for >10 seconds (see Web Figure 31) Probably reflex
Type 3. No (type 3A) or slight (type
3B) rhythm variations
Variations in HR <30% and HR >40 b.p.m (see Web Figures 32 and 33) Uncertain
Type 4. Tachycardia. Increase in HR
>30% or >120 b.p.m.
Type 4A. Progressive sinus tachycardia (see Web Figures 34) Uncertain
Type 4B. Atrial fibrillation Cardiac arrhythmia
Type 4C. SVT (except sinus) Cardiac arrhythmia
Type 4D. Ventricular tachycardia Cardiac arrhythmia
AV = atrioventricular; b.p.m. = beats per minute; ECG = electrocardiogram; HR = heart rate; ISSUE = International Study on Syncope of Unknown Etiology; SHD = structural
heart disease; SVT = supraventricular tachycardia.
Web Figure 27 Type 1A, sinus arrest. (A) Heart rate trend dur-
ing 42 min of loop recording. Initially, the heart rate is stable at
approximately 70 b.p.m.; at the beginning of the episode the HR
increases to 100 b.p.m., then decreases rapidly to a very low rate. (B)
The expanded electrocardiogram at the time of syncope shows pro-
longed multiple pauses due to sinus arrest. The noise recorded during
the pauses of 8 s and 19 s of asystole probably reflects jerking move-
ments of the patient. The finding of initial sinus tachycardia with pro-
gressive sinus bradycardia frequently followed by sinus arrest has
been regarded as highly suggestive of a neurally mediated mechanism.
b.p.m. = beats per minute; ECG = electrocardiogram; HR =
heart rate.
Web Figure 28 Type 1B, sinus bradycardia plus atrioventricu-
lar block. Progressive sinus bradycardia to <30 b.p.m. followed by
atrioventricular block (and long ventricular pauses) with concomi-
tant severe bradycardia. The association between atrioventricular
block and sinus arrest suggests a neurally mediated mechanism. 
indicates the time when the patient activated the recording. AV =
atrioventricular; b.p.m. = beats per minute.
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8.1.3 Type 1C, atrioventricular block
Web Figure 29 Type 1C, intrinsic atrioventricular block: patient with bundle branch block. (A) Heart rate trend during the whole 21-min loop
recording. Initially, the heart rate is stable at approximately 80 b.p.m. and suddenly falls at the time of the syncope. (B) The expanded electrocardiogram
shows blocked P waves with two main pauses of 5- and 6-s duration. The sinus rate increases during atrioventricular block. The noise recorded during
the second pause probably reflects jerking movements of the patient. The onset of atrioventricular block (and ventricular pause) was sudden and was ini-
tiated and ended by ventricular premature extrasystole. This pattern is opposite to the finding of Web Figures 27 and 28 and suggests a different mecha-
nism, namely an intrinsic disease of the His-Purkinje system as observed in Stokes–Adams attacks. AV = atrioventricular; b.p.m. = beats per minute; ECG
= electrocardiogram; HR = heart rate.
Web Figure 30 Type 1C, idiopathic (low-adenosine) atrioventricular block. Holter recording of two episodes of spontaneous syncope
(A and B), which occurred a few minutes apart. The two episodes were very similar and were characterized by sudden-onset complete atrioventricu-
lar block without changes in P-P cycle length, which remained constant at 720 ms (top traces A and B), and long ventricular asystole of 7 and 11 s,
respectively (bottom traces A and B). The patient had no structural heart disease, a normal electrocardiogram, and low values of plasmatic adenosine.
Contrary to the case shown in Web Figure 29, atrioventricular block was never initiated by atrial, His, or ventricular premature extrasystole, increased
heart rate (tachy-dependent atrioventricular block), or decreased heart rate (brady-dependent atrioventricular-block), all features that support a
diagnosis of intrinsic atrioventricular block. AV = atrioventricular.
e72 ESC Guidelines
D
ow
nloaded from
 https://academ
ic.oup.com
/eurheartj/article-abstract/39/21/e43/4939242 by Azienda O
spedaliera C
areggi user on 28 D
ecem
ber 2018
..
..
..
8.1.4 Type 2, bradycardia
8.1.5 Type 3, no or slight rhythm variations
8.1.6 Type 4, tachycardia
Web Figure 33 Type 3B. Slight variations (<10% variation in
heart rate). Heart rate trend during 7 min of loop recording. Initially,
the heart rate is approximately 90 b.p.m.; it progressively increases to
120 b.p.m. in a few minutes, then progressively decreases to 100
b.p.m. That value is reached roughly 1 min before multiple device acti-
vation by the patient () and thus is likely to coincide with the loss of
consciousness. The pattern of a progressive increase and then
decrease in heart rate is similar to the pattern observed during tilt
Web Figure 32 Type 3A. No variation in heart rate. Heart rate
trend during 21 min of loop recording. Heart rate is approximately
60 b.p.m. and remains stable throughout the recording period. 
indicates the time when the patient activated the recording after
resuming consciousness. The pattern of almost no variation in heart
rate excludes the participation of a cardiac reflex in the genesis of
the loss of consciousness; this means that reflex syncope is also
unlikely, although it cannot be definitely ruled out. b.p.m. = beats
per minute; HR = heart rate; LOC = loss of consciousness.
Web Figure 31 Type 2, bradycardia. The initial sinus tachycar-
dia 90 b.p.m. is followed by progressive sinus bradycardia until <30
b.p.m. for >10 s.  indicates the time when the patient activated
the recording. b.p.m. = beats per minute.
Web Figure 34 Type 4A progressive sinus tachycardia. Heart
rate trend during 7 min of loop recording. Initially, the heart rate is
approximately 100 b.p.m.; it then progressively increases up to 130
b.p.m., a value reached roughly 1 min before device activation by the
patient (), and thus is likely to coincide with the loss of consciousness.
The pattern of progressive heart rate increase is similar to a pattern
observed in some patients during tilt testing; this pattern is character-
ized by progressive tachycardia and hypotension, and is variously
defined as an ‘excessive heart rate rise’ or ‘orthostatic intolerance’. This
behaviour suggests that heart rate increases as part of an insufficient
compensatory attempt and indicates a sympathetic arousal. b.p.m. =
beats per minute; HR = heart rate; LOC = loss of consciousness.
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9. Practical Instructions for
section 5.2: treatment of reflex
syncope
9.1 European Society of Cardiology
information sheet for patients affected
by reflex syncope
This information sheet has been written for patients (and their rela-
tives and carers) who have been diagnosed with VVS. It is intended to
explain their diagnosis and treatment.
What is syncope?
Syncope is one of several conditions in which a person loses con-
sciousness for a short time, usually only a minute or two.
Syncope is caused by a reduction in the flow of blood to the brain.
The brain then stops working, the person loses consciousness and
falls, and will not know later what happened during that time.
There are several causes of syncope, such as problems with blood
pressure or the heart, but vasovagal syncope (VVS) is the most com-
mon cause: one in four people will have at least one attack of VVS
during their lives, but only 1 in 20 people will have at least five attacks,
and even fewer will have many more attacks. Sometimes the diagno-
sis of VVS is easy, but sometimes it is not. In the latter, the attacks
may at first look like epileptic seizures or a heart problem, in which
case the person is seen by a neurologist or cardiologist who usually
orders tests to investigate the brain and the heart.
The diagnosis of VVS
The diagnosis of VVS rests on specific clues from history taking,
meaning that your doctor asks you what triggers the attacks and
what happens to you during them. Typical triggers are pain, emotion,
seeing blood or having a blood sample taken, and standing for some
time. Other important clues are feeling nauseous, starting to sweat,
or turning very pale before the attacks. During the attacks, people fall
and, if they were upright, can hurt themselves. There can be a few
movements of the face and limbs and the person may become incon-
tinent. The unconsciousness typically lasts less than a minute and
then the person quickly becomes fully conscious. However, many
people feel very tired after the attack, and children especially may fall
asleep. These clues are the most importance evidence that a person
has VVS.
A ‘tilt table test’ can be used to test for VVS. This test tries to pro-
voke an attack, so that doctors can monitor your blood pressure and
heart rate during an attack and ask whether the attack is the same as
a spontaneous one.
What happens in the body during VVS?
VVS is brought about by a brain reflex. When triggered, the reflex
affects the circulation in two ways. First, blood vessels in the body
open too widely, blood moves down in the body, and blood pres-
sure drops. Second, the brain may ‘tell’ the heart to slow down
and even to stop temporarily (this is not a heart disease, but a
healthy heart receiving the wrong instruction). Either way, the cir-
culation of blood decreases. The brain is affected first because it
needs a lot of blood and because it is located at the top of the
body, making it a more difficult place to pump blood to.
Consciousness is lost when the brain stops working, and then the
person falls down. However, lying down helps to get blood back to
the brain and consciousness is quickly restored. This explains why
lying down helps to prevent fainting: it helps to restore blood pres-
sure and blood flow to the brain.
It is not known why some triggers, such as seeing blood, prompt
the reflex. We do know that anything that reduces blood pressure or
the amount of water in the body makes it easier to trigger the reflex,
such as not drinking much, eating very little salt, sweating a great deal,
diarrhoea, some drugs, warm places, and simply standing.
Preventing VVS
There are several things that you can do to prevent syncope. If you
feel a spell coming on, lying down is best, with your feet in the air.
Obviously, you cannot lie down everywhere, in which case you can
sit down or do ‘counter manoeuvres’ (tricks that raise blood pres-
sure). People who are prone to VVS should drink plenty of fluids and
eat salt, as salt is needed to keep the water in the body (unless there
are medical reasons to cut down on salt!). In most patients, these sim-
ple measures allow them to control the fainting tendency. In rare
cases, doctors may try drugs to increase the volume of blood and
blood pressure, and in very rare cases a pacemaker may be needed.
This is a last resort when nothing else works and when it has been
proven that the reflex makes the person’s heart stop temporarily.
9.2 Counter-pressure manoeuvres
The most commonly used manoeuvres are leg crossing, hand gripping,
and arm tensing186,192 (Web Figure 35). Patients with known susceptibil-
ity to neural reflex or orthostatic faints should be instructed to use
these manoeuvres as preventive measures when they experience any
Box. Actions to take to avoid an
impending attack of reflex syncope
(1) When you feel symptoms of syncope coming on, the best
response is to lie down. If this is not possible, then sit down and
do counter manoeuvres. The final warning symptom is when
everything goes dark and you lose vision: then you only have
seconds in which to prevent syncope.
(2) Your doctor will have shown you how to do the counter
manoeuvres. They all concern tensing large muscles in the
body. One way is to press the buttocks together and straighten
the knees forcefully; another is to cross your legs and press
them together over their entire length. Others make fists and
tense the arm muscles.
(3) Drink around 2 L of fluid a day and do not use salt sparingly
(unless there are medical reasons not to!). A simple way to tell
whether or not your fluid intake is high enough is to check the
colour of your urine: if it is dark yellow there is little fluid in your
body, so try to keep it very lightly coloured.
(4) Inform those in your immediate surroundings what to do during
a spell: in typical spells there is no need to call a doctor or an
ambulance. Of course, if you hurt yourself in the fall, this may
change.
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symptoms of impending fainting. Whichever of the manoeuvres is
employed, they can increase blood pressure rapidly and significantly,
thus aborting syncope for a sufficient period to permit the affected per-
son to achieve a safe position (e.g. if driving, pull the car to the side of
the road; if standing, sit or lie down) (Web Figure 36).
Physicalmanoeuvres for interrupting reflex or
orthostatic faints (Web Figure 35):
Leg crossing. Consists of leg crossing combined with maximum tensing
of leg, abdominal, and buttock muscles for the maximum tolerated
time or until complete the disappearance of symptoms. This proce-
dure is sometimes described in the literature as leg crossing with
muscle tensing. Leg crossing alone has also been shown to be useful
but is less powerful in terms of preventing hypotension.
Hand gripping. Consists of the maximal squeezing of a rubber ball
(approximately 5–6 cm in diameter) or a similar soft object taken in
the dominant hand, for the maximum tolerated time or until the
complete disappearance of symptoms (Web Figure 36).
Arm tensing. Consists of the maximum tolerated isometric contrac-
tion of the two arms achieved by gripping one hand with the other and
at the same time abducting (pulling away) the arms for the maximum
tolerated time or until the complete disappearance of symptoms.
Web Figure 35 Most common counter-pressure manoeuvres: leg crossing, hand gripping, and arm tensing.
Web Figure 36 Hand gripping. The start of the manoeuvre
causes a rapid rise in blood pressure, which persists as long as the
contraction is maintained; initially HR slightly increases and then
slightly decreases. BP = blood pressure; HR = heart rate.
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..10. Practical Instructions for
section 7: psychogenic transient
loss of consciousness
European Society of Cardiology
information sheet for patients affected
by psychogenic pseudosyncope
This information sheet is aimed at patients with psychogenic pseudo-
syncope as well as their relatives or carers. It is intended to explain
the diagnosis, treatment, and management of the condition.
What is psychogenic pseudosyncope?
Psychogenic pseudosyncope, or PPS, is one of the terms that doctors
may use to describe your spells. Take a look at what the words mean
on their own: ‘syncope’ means someone loses consciousness because
the brain temporarily does not get enough blood. A good example of
syncope is the ‘common faint’ (or vasovagal syncope, VVS), in which
people faint when they see blood or stand for some time. Adding
‘pseudo’ means that the spells look like syncope but are not really.
‘Psychogenic’ means that the spells have a psychological origin.
Together, the spells look as if someone loses consciousness because
the brain does not get enough blood, but in reality, the cause is psy-
chological. There are various other words for the psychological
nature of the attacks, such as ‘functional’.
What it does and does notmean
The ‘psychological’ part is difficult to understand. Certainly, people
with PPS do not pretend to have attacks. Instead, the attacks happen
to them—just as the common faint or a heart attack can happen—
and all are beyond their control. Therefore, people with PPS should
not be blamed for these attacks, nor should they blame themselves.
People with PPS can suffer greatly from these spells: school, work,
and social life suffer, with some becoming distressed and depressed.
The problem must be taken seriously and addressed. Most people do
not like to hear that they have a psychological problem; this is under-
standable. Even so, understanding what the attacks are is the first
step to getting better.
People have such spells because of psychological stress.
Sometimes patients with PPS know quite well that they are struggling
with a problem, and sometimes they do not. Note that the spells
rarely occur at actual moments of stress; most often they occur
unexpectedly, without any trigger that doctors or patients can
identify.
Diagnosing
Patients sometimes believe that doctors think a problem is psycho-
logical because the doctor cannot think of any other reason. But that
is not how such a diagnosis is reached. Instead, specific features point
towards PPS, just as for any diagnosis.
After the diagnosis
For some patients, getting the diagnosis is a relief: they finally know
what they have. In some cases, just knowing what the problem is
reduces the frequency of the spells, and the spells may even disap-
pear altogether.
The spells indicate that something is causing stress, but not what it
is. The causes differ greatly between patients, and in some cases,
there is no obvious problem.
If the attacks do not go away a few months after the diagnosis, psy-
chiatric or psychological help may be needed. The therapy will usually
be a form of ‘cognitive behavioural therapy’, but the choice depends
on the nature of the problem and the therapist. It is difficult to predict
how well the patient will react to the therapy. This depends on many
things, such as how serious the underlying problem is. If it is serious,
having the spells may just be one expression of the problem, so there
may be other symptoms.
Dealingwith the attacks
After the diagnosis, patients and their relatives should understand
that the spells are not a medical emergency: the heart and brain are
not at any risk. There is no need to call a doctor or an ambulance for
such spells (unless, obviously, the patient hurts themselves).
During the period in which patients receive psychological therapy,
it may benefit the patient to speak with the doctor who made the
diagnosis, to answer remaining or new questions.
This sheet has been prepared in collaboration with Michela Balconia,c,
Claudio Lucchiarib, and Pier Luigi Baldic
aResearch Unit in Affective and Social Neuroscience, Catholic
University of Milan, Milan, Italy
bDepartment of Philosophy, Universita degli Studi di Milano, Milan,
Italy
cDepartment of Psychology, Catholic University of Milan, Milan, Italy
11. Practical Instructions for
section 9.2: the clinical nurse
specialist in the syncope unit
See Supplementary material online, Video 4.
Actions to take when there are attacks
of PPS
• Relatives or colleagues should know what a typical attack
looks like (usually patients look as if they are asleep but can-
not be woken).
• Relatives or colleagues should know beforehand what to do
during a typical attack.
• The attacks are not a medical emergency, so it is not neces-
sary to call an ambulance.
• The attacks will pass by themselves, but some patience is
required.
• Patients may be moved during an attack, if necessary.
• While waiting for the attack to end, patients may be put in a
comfortable position, such as lying on their side with a pillow
under the head.
• People close to the patient may stay next to the patient and
comfort them when they recover, as they are then often
emotionally distressed.
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